Company intelligence / Profile preview

TMS Solutions

Grand Junction, Colorado, USAtmssolutions.com ↗

Ownership: Private
Development stage: Commercial

Overview

TMS Solutions provides FDA-cleared Transcranial Magnetic Stimulation therapy for treatment-resistant depression and other mental health conditions. The company has administered over 80,000 treatments since its founding in 2014. Clinical results show significant symptom reduction or remission for many patients who have not responded to traditional therapies. The company participated as one of ten providers nationwide selected for an FDA adolescent clinical trial led by Mayo Clinic.

Therapeutic areas: Psychiatry
Modalities: DeviceNon-pharmacological therapySpecifically, Transcranial Magnetic Stimulation (TMS) therapy
Industry: Non-Academic Healthcare

Partnerships

Mayo Clinic adolescent clinical trial partnerU.S. Department of Veterans Affairs/VA insurance credentialed clinics

Beyond the preview

Go deeper on TMS Solutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TMS Solutions.

Explore the full profile